FDA Inspection 1207391 — Fresenius Kabi Austria GMBH
The FDA completed an inspection of Fresenius Kabi Austria GMBH on October 13, 2022 in Graz. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 13, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Graz (Austria)
Additional Details
Mutual Recognition Agreement (MRA)